Anders Named Medical Director For DCI Center For Brain & Spine Metastasis; Joins Breast Oncology

January 14, 2019
By: Julie Poucher Harbin, Writer, DCI

Medical oncologist Carey Anders, MD, has been appointed medical director for the DCI Center for Brain and Spine Metastasis and has joined the Breast Medical Oncology group. She has also been named a Translating Duke Health (TDH) Scholar by the Duke University Office of the Chancellor. 

Previously, Anders was leader of the University of North Carolina at Chapel Hill Breast Section, co-director of the UNC Lineberger Breast Program, director of UNC Lineberger Breast Cancer Clinical Trials, and associate professor of Medicine at the UNC School of Medicine. 

Anders received her medical degree from the Brody School of Medicine at East Carolina University in Greenville, North Carolina, and completed both a residency in Internal Medicine (2002-2005) and a clinical fellowship in Hematology-Oncology (2005-2008) at Duke University Medical School. She is board certified in both Medical Oncology and Internal Medicine.

As a fellow at Duke (2005-2008), her research examined age-specific genomic differences in human breast carcinoma. Anders’ primary research focus as faculty at UNC addressed brain metastases arising from breast cancer.   

“My ultimate research goal is to uncover genetic and genomic underpinnings of breast cancer brain metastases, test novel strategies in the laboratory, and ultimately translate my findings into rationally-designed therapeutics to treat this aggressive disease,” said Anders, who’s been the recipient of numerous awards to further her research including from Duke, the National Cancer Institute, the American Society of Clinical Oncology, and private foundations.